Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 receptor agonists on bone strength in postmenopausal women with T2DM
NCT04964388Phase 2Terminated
- Sponsor
- University of Mississippi Medical Center
- Start
- Nov 2021
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial in osteoporosis (2 cohorts), sponsored by University of Mississippi Medical Center. Primary endpoint: Trabecular Bone Score at 12 months. Started Nov 2021; status: terminated.
02
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04964388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04964388.